Skip to end of metadata
Go to start of metadata
You are viewing an old version of this page. View the current version.
Compare with Current
View Page History
Version 1
Current »
Project Scope |
We propose beginning this project by identifying CtQ factors via a risk assessment process (characterising risk including assessment and mitigation/risk reduction strategies), which would include identifying trial-level QTLs that support CtQ factors. |
Problem Statement |
---|
Conducting a risk assessment for a clinical trial (a pre-competitive set of activities) can be time-intensive and may not be consistently focused on relevant critical to quality (CtQ) risks. Defining and recommending enhanced approaches and best practices may help increase the effectiveness and efficiency of this critical activity. Refining the risk assessment process (to include identifying CtQs and how they align with intercurrent events/estimands (ICEs) and the application of quality tolerance limits (QTLs)) can help ensure the scientific question is answered and the data collected is reliable and interpretable for the planned analysis. |
Problem Impact |
---|
Increased stakeholder support and participation. More meaningful risk assessments. Ability to re-use information collected in processes downstream from risk assessment, to enhance effectiveness and efficiency. |
|
---|
- New Project approved
- Currently calling for volunteers
|
Objectives & Deliverables | Timelines |
---|
Kick off and team formation | Q4 2024 |
Align on project parameters | Q4 2024 |
- Form sub-teams to work in parallel on specific components of the project:
- Why conduct an effective risk assessment
- How to complete an effective risk assessment
- Incorporating success stories to illustrate key points.
| Q4 2024 - Q1 2025 |
Complete and Integrate the First Wave of the Sub-Team Work: | Q1 2025 |
Review and Align the Results as a Whole Team to Consolidate the Sub-Team Outputs into a Comprehensive White Paper | Q2 2025 |
Finalise and Review the White Paper | Q3 2025 |
Define and Strategise the Second Wave of the Sub-Team Work | Q4 2025 |